Bowen Acquisition Corp Faces Imminent Nasdaq Delisting; Deadline to Appeal Set for July 22, 2025
Bowen Acquisition Corp (NASDAQ: BOWN), a special purpose acquisition company, has received a notification from Nasdaq indicating that its securities are subject to delisting from the Nasdaq Global Market. The delisting is due to Bowen's failure to meet specific listing requirements, including minimum market value and shareholding criteria, for a sustained period. The company has been working to complete a business combination with Shenzhen Qianzhi BioTechnology Co. Ltd., which it believes will address these issues. Bowen has until July 22, 2025, to appeal Nasdaq's decision. If no appeal is made by this date, trading of Bowen's securities will be suspended on July 24, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bowen Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-020251), on July 18, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。